BioPharmX Corp BPMX Income Statement

Biopharmx corp (BPMX)

Income statement / TTM

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Dec'14	Sep'14	Jul'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10
Revenues, net
-	-	-	-	57	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods sold
-	-	-	-	83	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues, net
-	-	-	-	-	-	-	-	-	-	84	86	100	120	107	93	64	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods sold
-	-	-	-	-	-	-	-	-	-	499	507	516	264	255	248	237	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross margin
-	-	-	-	-26	-231	-171	-174	-177	-410	-415	-421	-416	-144	-148	-155	-173	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
REVENUES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Operating expenses:
Research and development
4,690	6,108	7,596	8,951	9,079	8,960	8,843	8,526	9,140	9,990	10,366	10,926	10,158	9,469	8,631	6,799	5,702	4,534	3,692	3,208	2,519	2,122	0	1,536	1,027	671	0	0	0	-	-	-	-	-	-	-	-	-
Sales and marketing
714	1,012	1,423	1,820	2,157	2,203	2,199	2,219	2,415	2,596	2,579	2,888	3,198	3,982	4,723	5,135	5,109	4,620	4,107	3,167	2,299	1,396	0	687	332	132	0	0	0	-	-	-	-	-	-	-	-	-
Professional fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	51	25	25	28	27	60	59	55	55	0	0	0
General and administrative
4,282	4,526	4,909	4,975	5,244	5,725	5,189	5,287	5,144	4,809	4,875	4,764	4,654	4,616	4,392	4,341	4,174	4,227	3,812	3,496	2,953	2,205	0	1,850	1,135	711	306	146	59	0	0	0	0	1	3	0	0	0
Total operating expenses
9,686	11,646	13,928	15,746	16,480	16,888	16,231	16,032	16,699	17,395	17,820	18,578	18,010	18,067	17,746	16,275	14,985	13,381	11,611	9,871	7,771	5,723	0	4,073	2,494	1,514	781	372	127	29	27	61	60	57	59	0	0	0
Interest Income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-
Loss from operations
-9,686	-11,644	-13,976	-15,783	-16,506	-17,119	-16,402	-16,206	-16,876	-17,805	-18,235	-18,999	-18,426	-18,211	-17,894	-16,430	-15,158	-12,686	-10,664	0	-	0	0	0	-	-1,514	-681	-271	-26	-29	-27	-61	-60	-57	-59	0	0	0
Change in fair value of warrant liability
-	0	82	103	-	33	160	662	364	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income (expense), net
-290	-832	-819	-797	-778	99	-69	-98	-126	-238	-137	-141	-141	-45	2	1	-436	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before provision for income taxes
-9,700	-12,480	-14,757	-16,521	-17,300	-16,987	-16,311	-15,642	-16,638	-17,884	-18,048	-19,341	-18,404	-17,922	-17,892	-16,429	-15,594	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76	0	-	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-
Provision for income taxes
2	2	2	2	2	3	3	3	2	1	1	1	2	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss and comprehensive loss
-9,687	-12,438	-14,715	-16,479	-17,258	-16,990	-16,314	-15,645	-16,640	-17,885	-18,049	-19,342	-18,406	-17,926	-17,898	-16,435	-15,598	-13,821	-12,036	-10,278	-7,807	-5,799	0	-4,185	-2,632	-1,588	0	0	0	-	-	-	-	-	-	-	-	-
Accretion on Series A convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	202	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend on Series A convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	201	0	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss available to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-16,001	-13,296	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividend on Series A convertible redeemable preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
Net loss available to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	-	-816	-385	-127	-29	-27	0	0	0	-	-	-	-
Basic and diluted net loss per share
-0.01	-0.14	-0.22	-0.38	-0.47	-0.57	-0.58	-0.61	-0.01	-0.05	-0.05	-0.08	-0.05	-0.12	-0.18	-0.17	-0.14	-0.18	-0.24	-0.33	-0.29	-0.20	-0.18	-0.18	-0.13	-0.10	-0.06	-0.04	-0.02	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	0.00
Shares used in computing basic and diluted net loss per share
15,334	14,672	12,245	9,433	8,412	7,654	7,653	7,189	121,914	79,659	74,357	67,670	57,095	31,253	28,674	26,202	23,579	21,037	15,443	11,741	-9,005,129	10,630	10,551	10,367	9,025,000	-7,368,949	7,025	7,400	7,383,000	-	-	-	-	-	-	-	-	-
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,000	9,000	9,000	9,000	9,000	9,000	9,000	9,000	9,177	9,000	7,666	7,000